We tested this further by re-running the regressions of NAS and steatohepatitis in each fibrosis stage separately (results provided in Supplementary Data 3 and 6), showing that these factors are not associated with CYP2C19 expression outside of the context of worsening fibrosis. The gene discussed is CYP2C19; the disease is neonatal abstinence syndrome.